Back to BCRX
Kestra Advisory Services, LLC → BCRX
Kestra Advisory Services, LLC BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$133K
Q3 2026
Peak value
$150K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $100K |
| Q4 2025 | $102K |
| Q1 2026 | $150K |
| Q2 2026 | $131K |
| Q3 2026 | $133K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $133K | 16.0K | — | — |
| Q2 2026 | $131K | 13.1K | — | — |
| Q1 2026 | $150K | 15.7K | — | — |
| Q4 2025 | $102K | 13.1K | — | — |
| Q3 2025 | $100K | 13.1K | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$151.9M
$151.9M
$116.2M